Find a trial

Our clinical trials database will help you look for a clinical trial that might be suitable for you. We hope this helps you to make informed decisions and choices about your lymphoma treatment and care.

Questions about Lymphoma TrialsLink and how to use it? Read more about Lymphoma TrialsLink here or if you have a general question about clinical trials in the UK or Lymphoma TrialsLink, please contact us at trialslink@lymphoma-action.org.uk.

Note: We are not able to refer people to specific trials. If you’re interested in taking part in a trial you have found on Lymphoma TrialsLink, we recommend that you print the trial summary and discuss it with your consultant. They can advise you on whether you might be eligible for the trial and how you can take part based on your individual circumstances.

Trial name	Closing date Sort ascending
JNJ-90009530: A phase 1 trial of JNJ-90009530 in people with relapsed or refractory B-cell Non-Hodgkin lymphoma	31 May 2039
EPCORE FL-2: A phase 3 trial of epcoritamab with rituximab and lenalidomide in people with untreated follicular lymphoma	1 Nov 2037
ALLCAR19: A phase 1 trial of CAR T-cell therapy in adults with relapsed or refractory DLBCL, CLL, SLL, FL or MCL	1 Dec 2033
BELLWAVE-010: A phase 3 trial of nemtabrutinib and venetoclax in people with relapsed or refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma	27 Jul 2033
Bellwave-011: A phase 3 trial of nemabrutinib in people with chronic lymphocytic leukaemia or small lymphocytic lymphoma	30 Sep 2032
RADAR: A phase 3 trial of an antibody treatment called brentuximab vedotin in people with early stage Hodgkin lymphoma	1 Sep 2032
REFRACT: A phase 2 trial comparing new treatments to standard treatment in relapsed or refractory follicular lymphoma	30 Nov 2031
OASIS II: A phase 2 trial of potential treatment regimens in people with mantle cell lymphoma	30 Sep 2031
TRANSCEND FL: a phase 2 trial of JCAR017 in relapsed or refractory low-grade B-cell non-Hodgkin lymphoma	30 Sep 2031
STATIC: A study comparing intermittent and continuous treatment with ibrutinib in CLL/SLL	1 Sep 2031
Glo-BNHL: a phase 2 and 3 trial testing odronextamab and loncastuximab tesirine in young people with relapsed or refractory B-cell non-Hodgkin lymphoma	1 May 2031
Soundtrack-E: A phase 1 and 2 trial of AZD0486 in people with B-cell lymphomas	25 Apr 2031
ABBV-101: A phase 1 trial of ABBV-101 in people with relapsed or refractory B-cell lymphomas	1 Mar 2031
Mahogany: A phase 3 trial of zanubrutinib and anti-CD20 in people with relapsed or refractory follicular or marginal zone lymphoma	1 Jun 2030
SGN35T-001: A phase 1 trial of SGN-35T in people with relapsed and refractory lymphomas	30 Apr 2030
RAINBOW: a randomised, phase 2/3 trial comparing ibrutinib plus rituximab with standard treatment in people with Waldenström’s macroglobulinaemia	1 Mar 2030
BO43243: A phase 1 trial of mosunetuzumab in relapsed or refractory chronic lymphocytic leukaemia (CLL)	28 Feb 2030
ELM-2: a phase 2 trial assessing the safety of odronextamab in adults with relapsed or refractory B-cell non-Hodgkin lymphoma	21 Dec 2029
Determine trial treatment arm 1: A phase 2/3 trial of alectinib in people with ALK positive lymphomas	1 Oct 2029
EPCORE CLL-1: A trial testing epcoritamab in people with relapsed or refractory chronic lymphocytic leukaemia and Richter’s syndrome	1 Aug 2029
OLYMPIA-2: A phase 3 trial of odronextamab in people with relapsed or refractory follicular lymphoma	29 Jul 2029
Athena 1: A phase 1 study of REGN5837 in people with relapsed or refractory B-cell non-Hodgkin lymphomas	16 May 2029
EBV: A phase 2 trial of tabelecleucel in people with Epstein-Barr virus associated diseases	1 May 2029
RITZ: a phase 3 trial testing zanubrutinib with rituximab in adults with untreated splenic marginal zone lymphoma	1 May 2029
SGN-35C: A phase 2 trial of the treatment SGN-35C in people with advanced lymphomas	4 Apr 2029
OLYMPIA-1: A phase 3 trial of odronextamab in people with untreated follicular lymphoma	3 Apr 2029
LIGHTBEAM-U01 (substudy 01A): a phase 1 and 2 trial testing zilovertamab vedotin in young people with relapsed or refractory DLBCL or Burkitt lymphoma	31 Mar 2029
CO43805: A Phase 1b trial of mosunetuzumab or glofitamab in people with B-cell Non-Hodgkin Lymphoma	7 Mar 2029
SYMPHONY-1: a phase 1b/3 double-blind, randomised study of tazemetostat or placebo in combination with lenalidomide plus rituximab in subjects with relapsed/refractory follicular lymphoma	1 Mar 2029
OLYMPIA-5: A phase 3 trial of odronextamab in people with relapsed or refractory follicular or marginal zone lymphoma	23 Jan 2029
ReVenG: A phase 2 trial of venetoclax and obinutuzumab in people with relapsed chronic lymphocytic leukaemia	1 Jan 2029
CaDAnCe-101: A phase 1 and 2 trial of the treatment BGB-16673 in people with B-cell lymphomas	31 Dec 2028
GOLSEEK-2: A phase 2 trial testing golcadomide with rituximab in adults with newly diagnosis advanced follicular lymphoma	27 Nov 2028
MK-3475A-F65: A phase 2 trial of pembrolizumab (MK-3475) in people with relapsed or refractory classical Hodgkin lymphoma and primary mediastinal large B-cell lymphoma	8 Nov 2028
ZEBRA: a phase 2 trial of zanubrutinib and rituximab in people with mantle cell lymphoma	1 Oct 2028
OLYMPIA-3: A phase 3 trial of odronextamab in people with diffuse large B-cell lymphoma	18 Sep 2028
BGB-11417 (WM): A phase 2 trial of BGB-11417 in people with relapsed or refractory Waldenstrom’s Macroglobulinaemia	1 Sep 2028
OptiMATe: A phase 3 trial to optimise the MATRix chemotherapy regimen in primary central nervous system lymphoma	31 Aug 2028
PORTAL: a phase 2 trial testing polatuzumab vedotin, obinutuzumab and glofitamab in adults with relapsed or refractory large B-cell lymphoma	30 Jul 2028
RELATIVITY-069: A phase 1/2 trial of relatlimab plus nivolumab in children and young adults with relapsed or refractory classic Hodgkin and Non-Hodgkin lymphoma	5 Jul 2028
NX-1607: A phase 1 study of NX-1607 in adults with advanced solid tumours	28 Feb 2028
NX-5948-301: A phase 1 study of a new treatment called NX-5948 in adults with relapsed or refractory B-cell lymphoma	1 Jan 2028
ALETA-001: A phase 1 and 2 trial of ALETA-001 in patients with relapsed or refractory non-Hodgkin lymphoma	1 Dec 2027
JNJ-90014496: A phase 1 trial of JNJ-90014496 in people with relapsed or refractory B-cell non-Hodgkin lymphoma	28 Oct 2027
waveLINE-003: A trial testing zilovertamab vedotin (MK-2140) in people with relapsed or refractory diffuse large B-cell lymphoma	24 Sep 2027
EPCORE DLBCL-3: A phase 3 trial of epcoritamab with or without lenalidomide in patients with diffuse large B-cell lymphoma	31 Jul 2027
REMoDL-A: A phase 2 trial of a targeted drug called acalabrutinib added to standard treatment for people with diffuse large B-cell lymphoma	1 Jul 2027
GLOBRYTE: A phase 3 trial of glofitamab in people with relapsed or refractory mantle cell lymphoma	30 Jun 2027
ABBV-525: A phase 1 trial of ABBV-525 in people with B-cell lymphomas	27 Jun 2027
ALLELE: A phase 3 trial of a targeted treatment called tabelecleucel in people with post-transplant lymphoproliferative disorder	1 Jun 2027
STELLAR: a phase 2 trial of acalabrutinib in people with Richter syndrome	31 May 2027
MK-2140-006: A trial testing zilovertamab vedotin in people with selected B-cell lymphoma	26 Apr 2027
CC-99282: A phase 1 trial of CC-99282 alone and in combination with anti-lymphoma agents in people with relapsed or refractory non-Hodgkin lymphoma	18 Apr 2027
DTP3: A phase 1/2 trial of DTP3 in people with relapsed or refractory diffuse large B cell lymphoma (DLBCL)	31 Mar 2027
CCS1477-02: a phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma	31 Mar 2027
PRO-CAR-T: A study to design and test a tool to gather information from patients after CAR-T therapy	31 Mar 2027
MK-1026: A phase 2 trial of nemabrutinib (MK-1026) in people with certain types of relapsed or refractory non-Hodgkin lymphoma	19 Mar 2027
PROCLIPI: a study aiming to identify factors important in predicting the outcome of cutaneous (skin) lymphomas, mycosis fungoides and Sezary syndrome	1 Mar 2027
CAN3001: A long term study of ibrutinib	29 Jan 2027
MOGAT: A phase 2 trial of mogamulizumab in cutaneous T-cell lymphoma	1 Jan 2027
PRiZM+: A phase 1 trial of zanubrutinib in people with relapsed or refractory primary central nervous system lymphoma	20 Oct 2026
JNJ-80948543: A phase 2 trial testing JNJ-80948543 in adults with relapsed and refractory DLBCL	21 Sep 2026
MAST: A trial investigating the link between gut health and stem cell transplant outcomes in patients with chronic lymphocytic leukaemia	31 Aug 2026
NuTide:701: a phase 1 trial to find the best dose and test the safety of a new drug called NUC-7738 in people with advanced solid tumours or lymphoma	1 Aug 2026
Kite: A trial testing KITE-363 and KITE-753 in people with relapsed and refractory B-cell lymphoma	1 Jul 2026
PRIMAVERA: a phase 1/2 trial testing AZD3470 in people with relapsed or refractory lymphoma	8 May 2026
CPI-0209: A study of CPI-0209 in relapsed or refractory diffuse large B-cell and peripheral T-cell lymphomas	1 Mar 2026
BOOST: studying samples from stem cell transplant donors and recipients to improve transplant success rates and reduce side effects	31 Dec 2025
STP938: A phase 1/2 study of STP938 for adults with relapsed or refractory B-cell and T-cell lymphomas	31 Dec 2025
NVG-111: a phase 1/2 trial of NVG-111 in relapsed or refractory chronic lymphocytic leukaemia, small lymphocytic lymphoma and mantle cell lymphoma	1 Dec 2025
BYON4228: A phase 1 trial of BYON4228 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma	1 Dec 2025
PETReA: a trial testing whether PET scans can help make treatment decisions for people with follicular lymphoma	31 Oct 2025
BASILICA-A: A study into why anaplastic large cell lymphoma sometimes occurs after breast implants	30 Sep 2025
DIRECT: A study looking at genetic changes in diffuse large B-cell lymphoma and other types of high-grade B-cell lymphoma	1 Sep 2025
WaveLINE-006: a phase 2 trial testing zilovertamab vedotin in adults with relapsed or refractory B-cell lymphoma	30 Apr 2025